An interventional study of SIA in Colo-rectal Cancer, sponsored by Vejle Hospital. Completed at 1 site in Denmark. Open to participants aged 18 Years and older. Per ClinicalTrials.gov, last updated 2026-05-06.
Sponsored by Vejle Hospital · Not applicable, Interventional, and Treatment
A single-arm, single-center prospective study of a novel double purse-string technique for constructing the colorectal anastomosis in robot-assisted laparoscopic resection of the sigmoid colon for cancer.
In all, 30 consecutive patients will be enrolled. The first 5 will be regarded as a pilot series for testing and aligning the study setup. The next 25 patients will form the study group. The clinical outcomes will be compared with historical control patients from our own department. Safety and feasibility will be assessed by short-term clinical outcomes.
1,432 studies on the registry are indexed under Colonic Neoplasms; 357 are open to participants now.
This study's enrollment of 39 is below the median of 90 across 1,034 interventional studies indexed under Colonic Neoplasms.
Browse Colonic Neoplasms studies →Vejle Hospital is the lead sponsor of 93 studies on the registry; 13 are open to participants now.
Counted across the registry records on this site, refreshed daily.
Exclusion Criteria:
Robot-assisted laparoscopic resection of sigmoid colon with colorectal anastomosis constructed by the double purse-string technique
Procedure: SIA
As indicated by arm description
Technical success
Successful construction of anastomosis by double purse-string technique
Time frame: 30 days
Complications
Surgical complications graded by Clavien-Dindo
Time frame: 30 days
Mortality
Postoperative death
Time frame: 30 days
LOS
Length of stay - number of days from day of operation to discharge
Time frame: 90 days
Readmissions
Unplanned hospital admissions at least 24 hs after discharge
Time frame: 30 days
Operation time
Duration of operation from incision to last skin stitch
Time frame: 30 days
Blood loss
Estimated intraoperative blood loss in ml
Time frame: 30 days
Medical complications
Medical complications graded by Clavien-Dindo and MESS
Time frame: 30 days
Plan to share: No
No publications or documents are linked to this record.
This study is completed, as verified in Apr 2026. You cannot join it, but the record below documents what was studied.
Get an email when the registry record changes — status, dates, results — or when someone posts here.
Sign in to followQuestions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.
Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.
Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.
Vejle Hospital